[Asia Economy Reporter Park Junyi] HLB Pharmaceutical announced on the 24th that it will exercise the conversion rights of 17,688 bearer subordinated unsecured private convertible bonds. This amounts to 200 million KRW, and the scheduled listing date is the 9th of next month.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
